Andres 2007.
Methods | Randomised trial | |
Participants | 112 participants with type 2 diabetes (intervention 58; control 56) 144 community pharmacies in the province of Pontevedra Spain 26 pharmacists Year of study: February 2003 to March 2004. |
|
Interventions | Drug knowledge was assessed by pharmacists using the "Dáder" method (a process for pharmacist follow‐up of patients who are receiving medication). Compliance with medication was assessed using a modified Morisky‐Green questionnaire. Every 3 months Duration 12 months |
|
Outcomes | HbA1C | |
Notes | Published in Spanish Funding source: Not specified Conflict of interest: Not stated |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | No information of randomisation procedure provided |
Allocation concealment (selection bias) | Unclear risk | No relevant information found |
Blinding of participants and personnel (performance bias) All Outcomes/Outcome 1 | High risk | In this complex intervention, the personnel are unlikely to have been blinded; implications for performance bias are unclear |
Blinding of outcome assessment (detection bias) All Outcomes/Outcome 1 | Low risk | HBA1c is unlikely to be biased by outcome assessors |
Incomplete outcome data (attrition bias) All outcomes | Low risk | Low dropout rate. Between group attrition < 10%. |
Selective reporting (reporting bias) | Low risk | All main results reported |
Other bias | Low risk | None |